Skip to content

The application of Cutaneous silent periods in diagnosis and differential diagnosis of early stage PD

The application of Cutaneous silent periods in diagnosis and differential diagnosis of early stage PD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091103
Enrollment
Unknown
Registered
2024-10-21
Start date
2022-07-01
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parkinson disease

Interventions

Gold Standard:PD: Meets the 2015 MDS diagnostic criteria of Parkinson's disease and the 2016 version of Chinese diagnostic criteria of Parkinson's disease. PDS :Meets the criteria of Parkinson's syndr
Index test:Cutaneous silent periods

Sponsors

Guangdong Provincial People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: PD group. 1) meet the 2015 International Association of dyskinesia (MDS) Parkinson's Disease Diagnostic criteria and the 2016 version of Chinese Parkinson's Disease Diagnostic criteria; 2) the age is 50-70 years old, the course of disease is less than 5 years, and the H&Y stage = II stage; 3) volunteer to participate in this researcher and could cooperate in completing all examination items. Control group. Normal middle-aged and elderly people aged 50-70 without nervous system and peripheral nerve damage. PDS group. 1)Meets the criteria of Parkinson's syndrome in the 2016 edition of Chinese Parkinson's Disease Diagnostic criteria, and there is at least one absolute exclusion criterion for Parkinson's disease. 2) the age was 50-70 years old, the course of disease was less than 5 years, and the H&Y stage was = II. 3) voluntarily participated in this researcher and could cooperate to complete all the examination items

Exclusion criteria

Exclusion criteria: 1) patients with pacemakers or other conditions are not suitable for electrophysiological examination, 2) patients with a clear history of peripheral neuropathy, 3) patients with diabetes, alcohol dependence or drug addiction, 4 ) patients with rheumatic immune diseases, HIV infection, history of gastrointestinal surgery and severe damage of liver and kidney function. ? Patients who undergo surgical implantation of electrodes for deep brain stimulation therapy; Same as the first part.

Design outcomes

Primary

MeasureTime frame
duration;end latency;AUC;

Secondary

MeasureTime frame
onset latency;sympathetic skin responses;sensitivity;specificity;

Countries

China

Contacts

Public ContactXie Chunge

Guangdong Provincial People’s Hospital

xiaokrlian@126.com+86 137 6074 0983

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026